44.95
price up icon2.79%   1.2508
 
loading

Vaxcyte Inc Azioni (PCVX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
25.13%
226.22
180.79 162.17 139.92 152.98
Operating Income/Loss
25.13%
-226.22
-180.79 -162.17 -139.92 -152.98
Nonoperating Income/Loss
48.84%
59.65
40.08 - - -
Income/Loss From Continuing Operations Before Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Net Income/Loss
18.37%
-166.57
-140.72 -137.08 -103.12 -128.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Diluted Average Shares
0.25%
136.03
135.69 4.4009 123.69 117.26
Basic Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Diluted Earnings Per Share
17.31%
-1.22
-1.04 -1.02 -0.83 -1.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.76
price up icon 1.09%
$22.86
price up icon 7.26%
$32.56
price up icon 2.34%
$102.75
price up icon 0.73%
$165.96
price up icon 2.22%
biotechnology ONC
$330.21
price up icon 3.25%
Capitalizzazione:     |  Volume (24 ore):